Cargando…
Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides—Where Are We Now
SIMPLE SUMMARY: Neuroendocrine neoplasms (NENs) are a rare and diverse group of malignancies which are rising in incidence. Several treatments have been devised for unresectable or metastatic tumors, including peptide receptor radionuclide therapy (PRRT). PRRT specifically targets cells that express...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833798/ https://www.ncbi.nlm.nih.gov/pubmed/35159027 http://dx.doi.org/10.3390/cancers14030761 |